Author： Brooks G. Goss M.W. Rozengurt E. Galinanes M.
Publisher： Academic Press
ISSN： 0022-2828
Source： Journal of Molecular and Cellular Cardiology, Vol.29, Iss.8, 1997-08, pp. : 2273-2283
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
The signal transduction pathways that mediate the cardioprotective effects of ischemic preconditioning remain unclear. Here we have determined the role of a novel kinase, protein kinase D (PKD), in mediating preconditioning in the rat heart. Isolated rat hearts (n=6/group) were subjected to either: (i) 36 min aerobic perfusion (control); (ii) 20 min aerobic perfusion plus 3 min no-flow ischemia, 3 min reperfusion, 5 min no-flow ischemia, 5 min reperfusion (ischemic preconditioning); (iii) 20 min aerobic perfusion plus 200 nmol/l phorbol 12-myristate 13-acetate (PMA) given as a substitute for ischemic preconditioning. The left ventricle then was excised, homogenized and PKD immunoprecipitated from the homogenate. Activity of the purified kinase was determined following bincubation with [gamma32P]-ATP±syntide-2, a substrate for PKD. Significant PKD autophosphorylation and syntide-2 phosphorylation occurred in PMA-treated hearts, but not in control or preconditioned hearts. Additional studies confirmed that recovery of LVDP was greater and initiation of ischemic contracture and time-to-peak contracture were less, in ischemic preconditioned hearts compared with controls (P<0.05). Our results suggest that the early events that mediate ischemic preconditioning in the rat heart occur via a PKD-independent mechanism.
Related content
By Baines C.P. Wang L. Cohen M.V. Downey J.M.
Journal of Molecular and Cellular Cardiology, Vol. 30, Iss. 2, 1998-02 ,pp. :
Access to resources
Recommend
Journal of Molecular and Cellular Cardiology, Vol. 28, Iss. 5, 1996-05 ,pp. :